Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Mengli, Huang"'
Publikováno v:
Shipin gongye ke-ji, Vol 45, Iss 17, Pp 163-173 (2024)
In order to efficiently extract pumpkin seed oil and fully realize its application value, continuous phase transition extraction (CPE) was applied to extract pumpkin seed oil in this study. The effects of extraction temperature, extraction time, extr
Externí odkaz:
https://doaj.org/article/7d0d7612f1784f87a85841ef104c4419
Autor:
Fengyun Pei, Wan He, Yinghua Duan, Qijun Yao, Yandong Zhao, Xinjuan Fan, Shuai Liu, Haiyang Chen, Fang He, Tingzhi Liu, Jiaoting Chen, Yijia Zheng, Heping Li, Xiaofang Guo, Lishuo Shi, Li Ling, Yaoxu Chen, Jiapeng He, Miao Liu, Mengli Huang, Yuezong Bai, Jianping Wang, Meijin Huang, Jun Huang
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Patients with DNA mismatch repair‐proficient/microsatellite stable (pMMR/MSS) colorectal cancer (CRC), which accounts for 85% of all CRC cases, display a poor respond to immune checkpoint inhibitors (i.e., anti‐PD‐1 antibodi
Externí odkaz:
https://doaj.org/article/478e2f55036f4d94b5bcf65305acb66a
Publikováno v:
Shipin Kexue, Vol 44, Iss 23, Pp 71-76 (2023)
The Longissimus dorsi muscle of sheep was treated at different times postmortem with dielectric barrier discharge (DBD) low temperature plasma and evaluated for pH, total number of bacteria, myofibrillar fragmentation index (MFI) and myofibril ultras
Externí odkaz:
https://doaj.org/article/a696afdc5cae47e3a555e2b4aa196c27
Autor:
Guozhen Yang, Xiaodong Su, Yuanheng Huang, Guangyu Luo, Zhiqiang Wang, Peiqiang Cai, Yating Zheng, Ting Bei, Mengli Huang, Yuezong Bai, Haoqiang He, Jin Xiang, Muyan Cai, Jiudi Zhong, Qiyu Guo, Xu Zhang
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Two cycles of neoadjuvant PD-1 blockade plus chemotherapy induced favorable pathological response and tolerant toxicity in patients with locally advanced esophageal squamous cell carcinoma (ESCC). However, approximately 25% of pat
Externí odkaz:
https://doaj.org/article/833b3f4cc1c84667bf397de83432f82f
Autor:
Senmiao Huang, Dianhe Li, Yongye Huang, Guojie Lu, Ying Tian, Xuefeng Zhong, Yating Zheng, Mengli Huang, Fuxi Huang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Systemic chemotherapies are the primary treatment options for patients with unresectable and metastatic intrahepatic cholangiocarcinoma (ICC), but the effectiveness of current systemic therapies is limited. The development of targeted-therapy has cha
Externí odkaz:
https://doaj.org/article/3bec38c3f5c9423d9b264a84af028492
Autor:
Kai Yan, Ding Zhang, Yanan Chen, Wenfeng Lu, Mengli Huang, Jinping Cai, Shiqing Chen, Ting Bei, Yuezong Bai, Jian Lv, Yong Fu, Haibin Zhang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Background & aimsLittle is known about molecular biomarkers that predict the response and prognosis in unresectable hepatocellular carcinoma (HCC) treated with programmed death (PD)-1 inhibitors.MethodsA total of 62 HCC patients who underwent next-ge
Externí odkaz:
https://doaj.org/article/ecf8df2a6f7f4c62b65c33f01eca316d
Autor:
Yuyan Xu, Jianpeng Cai, Kaihang Zhong, Yaohong Wen, Lei Cai, Guolin He, Hangyu Liao, Cheng Zhang, Shunjun Fu, Tingting Chen, Jinping Cai, Xuefeng Zhong, Chunzhu Chen, Mengli Huang, Yuan Cheng, Mingxin Pan
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundMinimal residual disease (MRD) is considered an essential factor leading to relapse within 2 years (early relapse) after radical surgery, which is challenging to be detected by conventional imaging. Circulating tumor DNA (ctDNA) provides a
Externí odkaz:
https://doaj.org/article/67a1acab6d4b4101b6caf9dcb603731e
Autor:
Xiaosong Xiang, Feilong Guo, Guoli Li, Long Ma, Xi Zhu, Zulpikar Abdulla, Jiafei Li, Junling Zhang, Mengli Huang
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundThe prognosis of unresectable gastric cancer is poor, while the efficacy of anti-PD antibodies has not been evaluated.MethodsPatients with unresectable gastric cancer who received intra-arterial chemotherapy (IAC) with sequential anti-PD-1
Externí odkaz:
https://doaj.org/article/ba57c267291b4616b5ef4a1ebc501c78
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) provide dramatic response to patients with advanced EGFR-mutant non-small cell lung cancer (NSCLC). However, the use of neoadjuvant therapy with EGFR-TKIs in EGFR-mutant N
Externí odkaz:
https://doaj.org/article/64b0dd0654654685a459ec0255a414b6
Autor:
Zhixuan You, Meng Lv, Xuanyu He, Yingqin Pan, Junfeng Ge, Xue Hu, Yating Zheng, Mengli Huang, Chengzhi Zhou, Changxuan You
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundNowadays, immunotherapy targeting immune checkpoint receptors is one of the cornerstones of systemic treatment in melanoma. Homologous recombination repair (HRR) is one of the DNA damage response (DDR) pathways, which has been proved to cor
Externí odkaz:
https://doaj.org/article/2f333e3230a4472696ab68591246bcab